Continuous Glucose Monitoring Device (CGMD) Market Share and Business Opportunities 2030
Continuous Glucose Monitoring Device (CGMD) Market: Strategic Insights
Continuous Glucose Monitoring Device (CGMD) Market
-
CAGR (2022 - 2030)14.1% -
Market Size 2022
US$ 9.8 Billion -
Market Size 2030
US$ 28.5 Billion
Market Dynamics
GROWTH DRIVERS
- Rising incidence of chronic diseases
- Demand for early diagnostic tools
FUTURE TRENDS
- Adoption of molecular diagnostics
- Advancements in lab automation
OPPORTUNITIES
- Growth in point-of-care diagnostic testing
- Expansion into emerging healthcare markets
Key Players
- B Braun SE
- F Hoffmann La Roche Ltd
- LifeScan Inc
- Medtronic
- Abbott Laboratories
- Ypsomed Holding AG
- Sensionics
- Nipro Corp
- GE Healthcare
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product
- Sensors
- Transmitters
- Receivers
Application
- Type 1 Diabetes and Type 2 Diabetes
Testing Site
- Fingertip Testing and Alternate Site Testing
End User
- Hospitals & Clinics and Self/Homecare